Source: DGNews | Posted 8 years ago
FDA Grants Approvable Letter For Fosrenol (Lanthanum Carbonate) For Treatment Related To Kidney Disease
Tags:
VANCOUVER, BC -- March 3, 2003 -- AnorMED Inc. (TSX:AOM) announced today that its licensee, Shire Pharmaceuticals Group plc, has received an approvable letter from the U.S Food & Drug Administration (FDA) for Fosrenol
Comments